Does tumour necrosis factor-alpha inhibitor infliximab induce histological resolution of pulmonary sarcoid granulomas?

The clinical respiratory journal

Volumn 1, Issue 2, 2007, Pages 106-113

  Milman, Nils ^a   Andersen, Claus B ^b   Baslund, B ^b   Loft, Annika ^b   Iversen, Martin ^b  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN, HUMAN; DIAGNOSTIC AGENT; DIFFERENTIATION ANTIGEN; FLUORODEOXYGLUCOSE F 18; INFLIXIMAB; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; RADIOPHARMACEUTICAL AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CASE REPORT; CHRONIC DISEASE; DRUG ANTAGONISM; DRUG EFFECT; GRANULOMA; HUMAN; LUNG; LYMPH NODE; MACROPHAGE; MALE; MEDIASTINUM; METABOLISM; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SARCOIDOSIS; SCINTISCANNING; THORAX;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CHRONIC DISEASE; FLUORODEOXYGLUCOSE F18; GRANULOMA; HUMANS; LUNG; LYMPH NODES; MACROPHAGES; MALE; MEDIASTINUM; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SARCOIDOSIS, PULMONARY; THORAX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955065050     PISSN: None     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2007.00023.x     Document Type: Article

References (0)